Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Apr 30;93(9):4240–4245. doi: 10.1073/pnas.93.9.4240

Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism.

C Missale 1, F Boroni 1, S Sigala 1, A Buriani 1, M Fabris 1, A Leon 1, R Dal Toso 1, P Spano 1
PMCID: PMC39519  PMID: 8633048

Abstract

Nerve growth factor (NGF) is well characterized for its neurotrophic actions on peripheral sensory and sympathetic neurons and on central cholinergic neurons of the basal forebrain. Recent evidence, however, has shown high levels of NGF to be present in a variety of biological fluids after inflammatory and autoimmune responses, suggesting that NGF is a mediator of immune interactions. Increased NGF serum levels have been reported in both humans and experimental animal models of psychological and physical stress, thus implicating NGF in neuroendocrine interactions as well. The possible source(s) and the regulatory mechanisms involved in the control of serum NGF levels, however, still remain to be elucidated. We now report the presence of both NGF gene transcripts and protein in the anterior pituitary. Immunofluorescence analysis indicated that hypophysial NGF is selectively localized in mammotroph cells and stored in secretory granules. NGF is cosecreted with prolactin from mammotroph cells by a neurotransmitter-dependent mechanism that can be pharmacologically regulated. Activation of the dopamine D2 receptor subtype, which physiologically controls prolactin release, resulted in a complete inhibition of vasoactive intestinal peptide-stimulated NGF secretion in vitro, whereas the specific D2 antagonist (-)-sulpiride stimulated NGF secretion in vivo, suggesting that the anterior pituitary is a possible source of circulating NGF. Given the increased NGF serum levels in stressful conditions and the newly recognized immunoregulatory function of this protein, NGF, together with prolactin, may thus be envisaged as an immunological alerting signal under neuronal control.

Full text

PDF
4240

Images in this article

4242Fig. 1
on p.4242
4243Fig. 3
on p.4243

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aloe L., Alleva E., Böhm A., Levi-Montalcini R. Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc Natl Acad Sci U S A. 1986 Aug;83(16):6184–6187. doi: 10.1073/pnas.83.16.6184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aloe L., Bracci-Laudiero L., Alleva E., Lambiase A., Micera A., Tirassa P. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10440–10444. doi: 10.1073/pnas.91.22.10440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aloe L., Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res. 1977 Sep 16;133(2):358–366. doi: 10.1016/0006-8993(77)90772-7. [DOI] [PubMed] [Google Scholar]
  4. Aloe L., Tuveri M. A., Carcassi U., Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum. 1992 Mar;35(3):351–355. doi: 10.1002/art.1780350315. [DOI] [PubMed] [Google Scholar]
  5. Badley J. E., Bishop G. A., St John T., Frelinger J. A. A simple, rapid method for the purification of poly A+ RNA. Biotechniques. 1988 Feb;6(2):114–116. [PubMed] [Google Scholar]
  6. Ben-Jonathan N. Dopamine: a prolactin-inhibiting hormone. Endocr Rev. 1985 Fall;6(4):564–589. doi: 10.1210/edrv-6-4-564. [DOI] [PubMed] [Google Scholar]
  7. Bischoff S. C., Dahinden C. A. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood. 1992 May 15;79(10):2662–2669. [PubMed] [Google Scholar]
  8. Caron M. G., Beaulieu M., Raymond V., Gagné B., Drouin J., Lefkowitz R. J., Labrie F. Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release. J Biol Chem. 1978 Apr 10;253(7):2244–2253. [PubMed] [Google Scholar]
  9. Conner J. M., Varon S. Nerve growth factor immunoreactivity in the anterior pituitary of the rat. Neuroreport. 1993 Apr;4(4):395–398. doi: 10.1097/00001756-199304000-00013. [DOI] [PubMed] [Google Scholar]
  10. Ehrhard P. B., Erb P., Graumann U., Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10984–10988. doi: 10.1073/pnas.90.23.10984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ehrhard P. B., Ganter U., Stalder A., Bauer J., Otten U. Expression of functional trk protooncogene in human monocytes. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5423–5427. doi: 10.1073/pnas.90.12.5423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ernfors P., Ibáez C. F., Ebendal T., Olson L., Persson H. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5454–5458. doi: 10.1073/pnas.87.14.5454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gala R. R. Prolactin and growth hormone in the regulation of the immune system. Proc Soc Exp Biol Med. 1991 Oct;198(1):513–527. doi: 10.3181/00379727-198-43286b. [DOI] [PubMed] [Google Scholar]
  14. Goedert M., Fine A., Dawbarn D., Wilcock G. K., Chao M. V. Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. Brain Res Mol Brain Res. 1989 Jan;5(1):1–7. doi: 10.1016/0169-328x(89)90011-9. [DOI] [PubMed] [Google Scholar]
  15. Hartikka J., Hefti F. Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymes. J Neurosci. 1988 Aug;8(8):2967–2985. doi: 10.1523/JNEUROSCI.08-08-02967.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hashimoto S., Fumagalli G., Zanini A., Meldolesi J. Sorting of three secretory proteins to distinct secretory granules in acidophilic cells of cow anterior pituitary. J Cell Biol. 1987 Oct;105(4):1579–1586. doi: 10.1083/jcb.105.4.1579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hempstead B. L., Martin-Zanca D., Kaplan D. R., Parada L. F., Chao M. V. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature. 1991 Apr 25;350(6320):678–683. doi: 10.1038/350678a0. [DOI] [PubMed] [Google Scholar]
  18. Hohn A., Leibrock J., Bailey K., Barde Y. A. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature. 1990 Mar 22;344(6264):339–341. doi: 10.1038/344339a0. [DOI] [PubMed] [Google Scholar]
  19. Huttner W. B., Gerdes H. H., Rosa P. The granin (chromogranin/secretogranin) family. Trends Biochem Sci. 1991 Jan;16(1):27–30. doi: 10.1016/0968-0004(91)90012-k. [DOI] [PubMed] [Google Scholar]
  20. Kannan Y., Ushio H., Koyama H., Okada M., Oikawa M., Yoshihara T., Kaneko M., Matsuda H. 2.5S nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils. Blood. 1991 Mar 15;77(6):1320–1325. [PubMed] [Google Scholar]
  21. Kaplan D. R., Hempstead B. L., Martin-Zanca D., Chao M. V., Parada L. F. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science. 1991 Apr 26;252(5005):554–558. doi: 10.1126/science.1850549. [DOI] [PubMed] [Google Scholar]
  22. Klein R., Jing S. Q., Nanduri V., O'Rourke E., Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell. 1991 Apr 5;65(1):189–197. doi: 10.1016/0092-8674(91)90419-y. [DOI] [PubMed] [Google Scholar]
  23. Klein R., Lamballe F., Bryant S., Barbacid M. The trkB tyrosine protein kinase is a receptor for neurotrophin-4. Neuron. 1992 May;8(5):947–956. doi: 10.1016/0896-6273(92)90209-v. [DOI] [PubMed] [Google Scholar]
  24. Klein R., Nanduri V., Jing S. A., Lamballe F., Tapley P., Bryant S., Cordon-Cardo C., Jones K. R., Reichardt L. F., Barbacid M. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell. 1991 Jul 26;66(2):395–403. doi: 10.1016/0092-8674(91)90628-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Korsching S. The neurotrophic factor concept: a reexamination. J Neurosci. 1993 Jul;13(7):2739–2748. doi: 10.1523/JNEUROSCI.13-07-02739.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lahtinen T., Soinila S., Lakshmanan J. Biological demonstration of nerve growth factor in the rat pituitary gland. Neuroscience. 1989;30(1):165–170. doi: 10.1016/0306-4522(89)90362-x. [DOI] [PubMed] [Google Scholar]
  27. Lamballe F., Klein R., Barbacid M. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell. 1991 Sep 6;66(5):967–979. doi: 10.1016/0092-8674(91)90442-2. [DOI] [PubMed] [Google Scholar]
  28. Laudiero L. B., Aloe L., Levi-Montalcini R., Buttinelli C., Schilter D., Gillessen S., Otten U. Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neurosci Lett. 1992 Nov 23;147(1):9–12. doi: 10.1016/0304-3940(92)90762-v. [DOI] [PubMed] [Google Scholar]
  29. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H., Barde Y. A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 1989 Sep 14;341(6238):149–152. doi: 10.1038/341149a0. [DOI] [PubMed] [Google Scholar]
  30. Leon A., Buriani A., Dal Toso R., Fabris M., Romanello S., Aloe L., Levi-Montalcini R. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3739–3743. doi: 10.1073/pnas.91.9.3739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Levi-Montalcini R., Dal Toso R., della Valle F., Skaper S. D., Leon A. Update of the NGF saga. J Neurol Sci. 1995 Jun;130(2):119–127. doi: 10.1016/0022-510x(95)00007-o. [DOI] [PubMed] [Google Scholar]
  32. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 1987 Sep 4;237(4819):1154–1162. doi: 10.1126/science.3306916. [DOI] [PubMed] [Google Scholar]
  33. Luppi P., Levi-Montalcini R., Bracci-Laudiero L., Bertolini A., Arletti R., Tavernari D., Vigneti E., Aloe L. NGF is released into plasma during human pregnancy: an oxytocin-mediated response? Neuroreport. 1993 Aug;4(8):1063–1065. doi: 10.1097/00001756-199308000-00018. [DOI] [PubMed] [Google Scholar]
  34. Maisonpierre P. C., Belluscio L., Squinto S., Ip N. Y., Furth M. E., Lindsay R. M., Yancopoulos G. D. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science. 1990 Mar 23;247(4949 Pt 1):1446–1451. doi: 10.1126/science.247.4949.1446. [DOI] [PubMed] [Google Scholar]
  35. Matsuda H., Coughlin M. D., Bienenstock J., Denburg J. A. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6508–6512. doi: 10.1073/pnas.85.17.6508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Matsuda H., Kannan Y., Ushio H., Kiso Y., Kanemoto T., Suzuki H., Kitamura Y. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med. 1991 Jul 1;174(1):7–14. doi: 10.1084/jem.174.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Missale C., Boroni F., Frassine M., Caruso A., Spano P. Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro. Endocrinology. 1995 Mar;136(3):1205–1213. doi: 10.1210/endo.136.3.7867574. [DOI] [PubMed] [Google Scholar]
  38. Murphy R. A., Chlumecky V., Smillie L. B., Carpenter M., Nattriss M., Anderson J. K., Rhodes J. A., Barker P. A., Siminoski K., Campenot R. B. Isolation and characterization of a glycosylated form of beta nerve growth factor in mouse submandibular glands. J Biol Chem. 1989 Jul 25;264(21):12502–12509. [PubMed] [Google Scholar]
  39. Näher-Noé M., Gnahn H., Grundler A., Klingelhöfer J., Weindl A., Conrad B. Determination of nerve growth factor concentrations in human samples by two-site immunoenzymometric assay and bioassay. Eur J Clin Chem Clin Biochem. 1993 Jun;31(6):375–380. doi: 10.1515/cclm.1993.31.6.375. [DOI] [PubMed] [Google Scholar]
  40. Onali P., Schwartz J. P., Costa E. Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6531–6534. doi: 10.1073/pnas.78.10.6531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Otten U., Baumann J. B., Girard J. Stimulation of the pituitary-adrenocortical axis by nerve growth factor. Nature. 1979 Nov 22;282(5737):413–414. doi: 10.1038/282413a0. [DOI] [PubMed] [Google Scholar]
  42. Otten U., Ehrhard P., Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10059–10063. doi: 10.1073/pnas.86.24.10059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Patterson J. C., Childs G. V. Nerve growth factor and its receptor in the anterior pituitary. Endocrinology. 1994 Oct;135(4):1689–1696. doi: 10.1210/endo.135.4.7925133. [DOI] [PubMed] [Google Scholar]
  44. Porter T. E., Hill J. B., Wiles C. D., Frawley L. S. Is the mammosomatotrope a transitional cell for the functional interconversion of growth hormone- and prolactin-secreting cells? Suggestive evidence from virgin, gestating, and lactating rats. Endocrinology. 1990 Dec;127(6):2789–2794. doi: 10.1210/endo-127-6-2789. [DOI] [PubMed] [Google Scholar]
  45. Radeke M. J., Misko T. P., Hsu C., Herzenberg L. A., Shooter E. M. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature. 1987 Feb 12;325(6105):593–597. doi: 10.1038/325593a0. [DOI] [PubMed] [Google Scholar]
  46. Rosa P., Weiss U., Pepperkok R., Ansorge W., Niehrs C., Stelzer E. H., Huttner W. B. An antibody against secretogranin I (chromogranin B) is packaged into secretory granules. J Cell Biol. 1989 Jul;109(1):17–34. doi: 10.1083/jcb.109.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Rosenthal A., Goeddel D. V., Nguyen T., Lewis M., Shih A., Laramee G. R., Nikolics K., Winslow J. W. Primary structure and biological activity of a novel human neurotrophic factor. Neuron. 1990 May;4(5):767–773. doi: 10.1016/0896-6273(90)90203-r. [DOI] [PubMed] [Google Scholar]
  48. Schechter J., Weiner R. Changes in basic fibroblast growth factor coincident with estradiol-induced hyperplasia of the anterior pituitaries of Fischer 344 and Sprague-Dawley rats. Endocrinology. 1991 Nov;129(5):2400–2408. doi: 10.1210/endo-129-5-2400. [DOI] [PubMed] [Google Scholar]
  49. Squinto S. P., Stitt T. N., Aldrich T. H., Davis S., Bianco S. M., Radziejewski C., Glass D. J., Masiakowski P., Furth M. E., Valenzuela D. M. trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell. 1991 May 31;65(5):885–893. doi: 10.1016/0092-8674(91)90395-F. [DOI] [PubMed] [Google Scholar]
  50. Taglialatela G., Angelucci L., Scaccianoce S., Foreman P. J., Perez-Polo J. R. Nerve growth factor modulates the activation of the hypothalamo-pituitary-adrenocortical axis during the stress response. Endocrinology. 1991 Oct;129(4):2212–2218. doi: 10.1210/endo-129-4-2212. [DOI] [PubMed] [Google Scholar]
  51. Tsuda T., Wong D., Dolovich J., Bienenstock J., Marshall J., Denburg J. A. Synergistic effects of nerve growth factor and granulocyte-macrophage colony-stimulating factor on human basophilic cell differentiation. Blood. 1991 Mar 1;77(5):971–979. [PubMed] [Google Scholar]
  52. Tsuruta K., Frey E. A., Grewe C. W., Cote T. E., Eskay R. L., Kebabian J. W. Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor. Nature. 1981 Jul 30;292(5822):463–465. doi: 10.1038/292463a0. [DOI] [PubMed] [Google Scholar]
  53. Ullrich A., Gray A., Berman C., Dull T. J. Human beta-nerve growth factor gene sequence highly homologous to that of mouse. Nature. 1983 Jun 30;303(5920):821–825. doi: 10.1038/303821a0. [DOI] [PubMed] [Google Scholar]
  54. Weskamp G., Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J Neurochem. 1987 Jun;48(6):1779–1786. doi: 10.1111/j.1471-4159.1987.tb05736.x. [DOI] [PubMed] [Google Scholar]
  55. Wolf D., Richter-Landsberg C., Short M. P., Cepko C., Breakefield X. O. Retrovirus-mediated gene transfer of beta-nerve growth factor into mouse pituitary line AtT-20. Mol Biol Med. 1988 Feb;5(1):43–59. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES